Charles Carrieri

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

Charles Carrieri is an author at Pfizer (United States) specializing in alzheimer's disease pharmacokinetics, cerebrospinal fluid biomarkers, and pharmacodynamics.

Publications per year

2009–2019

Publications

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, <scp>PF</scp>‐06648671, on <scp>CSF</scp> Amyloid‐β Peptides in Randomized Phase I Studies

Jae Eun Ahn, Charles Carrieri, Fernando Dela Cruz et al. · Clinical Pharmacology & Therapeutics · 2019 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

P2‐240: PF‐04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non‐clinical species to healthy human volunteers

Timothy Nicholas, Rebecca Evans, Scot Styren et al. · Alzheimer s & Dementia · 2009 · 24 citations

Life Sciences, Neuroscience, Pharmacology +17

1–2 of 2